Amneal prices $600M 6.875% senior secured notes due 2032, upsizes term loan to $2.1B

Amneal Pharmaceuticals, Inc.

$600M notes priced at par with 6.875% coupon, due 2032; downsized from $750M due to term loan increase.
New term B loans upsized to $2.1B from $1.8B, seven-year maturity.
Proceeds to refinance existing term B loans in full and repay ABL facility.
Closing expected August 1, 2025, subject to customary conditions.

item 8.01item 9.01

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.